Mechanisms of Cholera Toxin Prevention of Thrombin- and PMA-Induced Endothelial Cell Barrier Dysfunction

Carolyn E. Patterson, Harold W. Davis, Kane L. Schaphorst, Joe GN Garcia

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Thrombin-induced endothelial cell (EC) activation leads to compromise of monolayer barrier function due to cellular retraction/contraction and intercellular gap formation. Cyclic AMP induces relaxation in other contractile cells and promotes barrier function in EC. To investigate mechanisms involved in cAMP protection in thrumbin-induced permeability, we pretreated bovine pulmonary arterial EC monolayers with 1 μg/ml cholera holotoxin which catalyzed ADP ribosylation of G5 and increased synthesis of cAMp. The holotoxin, but not the binding subunit, reduced basal permeability and prevented gap formation and permeability following challenge with 1 μM thrumbin, 100 μM thrumbin receptor-activating peptide, or 1 μM phorbol myristate acetate (PMA). Furthermore, thrumbin-induced gap formation and permeability were reversed by cholera toxin post-treatment. Pretreatment with 5 μM forskolin or 1 mM dibutyryl cAMP, with or without 1 mM isobutyl methylxanthine, but not cGMP analogs, protected against thrumbin-induced EC permeability, mimicking the cholera toxin effect. Although downregulation of protein kinase C attenuated both thrumbin- and PMA-induced permeability, cholera toxin did not alter either PMA-induced protein kinase C activation or thrumbin-induced Ca2+ mobilization. In contrast, cholera toxin attenuated thrumbin-induced myosin light chain phosphorylation and largely prevented actin redistribution. These studies suggest that cholera toxin: (1) protects endothelial barrier function and reverses established dysfunction via increased cAMP, (2) does not alter thrombin receptor interaction or early signal events such as Ca2+ mobilization and PKC activation, (3) attenuates myosin light chain kinase activation and actomyosin contractile interaction subsequent to thrumbin activation, and (4) abrogates contractile processes subsequent to PKC activation, which is also an important mechanism in thrumbin-induced permeability but is independent of myosin light chain kinase activation.

Original languageEnglish (US)
Pages (from-to)212-235
Number of pages24
JournalMicrovascular Research
Volume48
Issue number2
DOIs
StatePublished - Sep 1994
Externally publishedYes

Fingerprint

Cholera Toxin
Endothelial cells
Tetradecanoylphorbol Acetate
Thrombin
Permeability
Endothelial Cells
Chemical activation
Myosin-Light-Chain Kinase
Protein Kinase C
Monolayers
Thrombin Receptors
Actomyosin
Myosin Light Chains
Phosphorylation
Peptide Receptors
Cholera
Colforsin
Cyclic AMP
Adenosine Diphosphate
Actins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Biochemistry

Cite this

Mechanisms of Cholera Toxin Prevention of Thrombin- and PMA-Induced Endothelial Cell Barrier Dysfunction. / Patterson, Carolyn E.; Davis, Harold W.; Schaphorst, Kane L.; Garcia, Joe GN.

In: Microvascular Research, Vol. 48, No. 2, 09.1994, p. 212-235.

Research output: Contribution to journalArticle

Patterson, Carolyn E. ; Davis, Harold W. ; Schaphorst, Kane L. ; Garcia, Joe GN. / Mechanisms of Cholera Toxin Prevention of Thrombin- and PMA-Induced Endothelial Cell Barrier Dysfunction. In: Microvascular Research. 1994 ; Vol. 48, No. 2. pp. 212-235.
@article{f6a8272600974476816ade2a47e31fd4,
title = "Mechanisms of Cholera Toxin Prevention of Thrombin- and PMA-Induced Endothelial Cell Barrier Dysfunction",
abstract = "Thrombin-induced endothelial cell (EC) activation leads to compromise of monolayer barrier function due to cellular retraction/contraction and intercellular gap formation. Cyclic AMP induces relaxation in other contractile cells and promotes barrier function in EC. To investigate mechanisms involved in cAMP protection in thrumbin-induced permeability, we pretreated bovine pulmonary arterial EC monolayers with 1 μg/ml cholera holotoxin which catalyzed ADP ribosylation of G5 and increased synthesis of cAMp. The holotoxin, but not the binding subunit, reduced basal permeability and prevented gap formation and permeability following challenge with 1 μM thrumbin, 100 μM thrumbin receptor-activating peptide, or 1 μM phorbol myristate acetate (PMA). Furthermore, thrumbin-induced gap formation and permeability were reversed by cholera toxin post-treatment. Pretreatment with 5 μM forskolin or 1 mM dibutyryl cAMP, with or without 1 mM isobutyl methylxanthine, but not cGMP analogs, protected against thrumbin-induced EC permeability, mimicking the cholera toxin effect. Although downregulation of protein kinase C attenuated both thrumbin- and PMA-induced permeability, cholera toxin did not alter either PMA-induced protein kinase C activation or thrumbin-induced Ca2+ mobilization. In contrast, cholera toxin attenuated thrumbin-induced myosin light chain phosphorylation and largely prevented actin redistribution. These studies suggest that cholera toxin: (1) protects endothelial barrier function and reverses established dysfunction via increased cAMP, (2) does not alter thrombin receptor interaction or early signal events such as Ca2+ mobilization and PKC activation, (3) attenuates myosin light chain kinase activation and actomyosin contractile interaction subsequent to thrumbin activation, and (4) abrogates contractile processes subsequent to PKC activation, which is also an important mechanism in thrumbin-induced permeability but is independent of myosin light chain kinase activation.",
author = "Patterson, {Carolyn E.} and Davis, {Harold W.} and Schaphorst, {Kane L.} and Garcia, {Joe GN}",
year = "1994",
month = "9",
doi = "10.1006/mvre.1994.1050",
language = "English (US)",
volume = "48",
pages = "212--235",
journal = "Microvascular Research",
issn = "0026-2862",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Mechanisms of Cholera Toxin Prevention of Thrombin- and PMA-Induced Endothelial Cell Barrier Dysfunction

AU - Patterson, Carolyn E.

AU - Davis, Harold W.

AU - Schaphorst, Kane L.

AU - Garcia, Joe GN

PY - 1994/9

Y1 - 1994/9

N2 - Thrombin-induced endothelial cell (EC) activation leads to compromise of monolayer barrier function due to cellular retraction/contraction and intercellular gap formation. Cyclic AMP induces relaxation in other contractile cells and promotes barrier function in EC. To investigate mechanisms involved in cAMP protection in thrumbin-induced permeability, we pretreated bovine pulmonary arterial EC monolayers with 1 μg/ml cholera holotoxin which catalyzed ADP ribosylation of G5 and increased synthesis of cAMp. The holotoxin, but not the binding subunit, reduced basal permeability and prevented gap formation and permeability following challenge with 1 μM thrumbin, 100 μM thrumbin receptor-activating peptide, or 1 μM phorbol myristate acetate (PMA). Furthermore, thrumbin-induced gap formation and permeability were reversed by cholera toxin post-treatment. Pretreatment with 5 μM forskolin or 1 mM dibutyryl cAMP, with or without 1 mM isobutyl methylxanthine, but not cGMP analogs, protected against thrumbin-induced EC permeability, mimicking the cholera toxin effect. Although downregulation of protein kinase C attenuated both thrumbin- and PMA-induced permeability, cholera toxin did not alter either PMA-induced protein kinase C activation or thrumbin-induced Ca2+ mobilization. In contrast, cholera toxin attenuated thrumbin-induced myosin light chain phosphorylation and largely prevented actin redistribution. These studies suggest that cholera toxin: (1) protects endothelial barrier function and reverses established dysfunction via increased cAMP, (2) does not alter thrombin receptor interaction or early signal events such as Ca2+ mobilization and PKC activation, (3) attenuates myosin light chain kinase activation and actomyosin contractile interaction subsequent to thrumbin activation, and (4) abrogates contractile processes subsequent to PKC activation, which is also an important mechanism in thrumbin-induced permeability but is independent of myosin light chain kinase activation.

AB - Thrombin-induced endothelial cell (EC) activation leads to compromise of monolayer barrier function due to cellular retraction/contraction and intercellular gap formation. Cyclic AMP induces relaxation in other contractile cells and promotes barrier function in EC. To investigate mechanisms involved in cAMP protection in thrumbin-induced permeability, we pretreated bovine pulmonary arterial EC monolayers with 1 μg/ml cholera holotoxin which catalyzed ADP ribosylation of G5 and increased synthesis of cAMp. The holotoxin, but not the binding subunit, reduced basal permeability and prevented gap formation and permeability following challenge with 1 μM thrumbin, 100 μM thrumbin receptor-activating peptide, or 1 μM phorbol myristate acetate (PMA). Furthermore, thrumbin-induced gap formation and permeability were reversed by cholera toxin post-treatment. Pretreatment with 5 μM forskolin or 1 mM dibutyryl cAMP, with or without 1 mM isobutyl methylxanthine, but not cGMP analogs, protected against thrumbin-induced EC permeability, mimicking the cholera toxin effect. Although downregulation of protein kinase C attenuated both thrumbin- and PMA-induced permeability, cholera toxin did not alter either PMA-induced protein kinase C activation or thrumbin-induced Ca2+ mobilization. In contrast, cholera toxin attenuated thrumbin-induced myosin light chain phosphorylation and largely prevented actin redistribution. These studies suggest that cholera toxin: (1) protects endothelial barrier function and reverses established dysfunction via increased cAMP, (2) does not alter thrombin receptor interaction or early signal events such as Ca2+ mobilization and PKC activation, (3) attenuates myosin light chain kinase activation and actomyosin contractile interaction subsequent to thrumbin activation, and (4) abrogates contractile processes subsequent to PKC activation, which is also an important mechanism in thrumbin-induced permeability but is independent of myosin light chain kinase activation.

UR - http://www.scopus.com/inward/record.url?scp=0027986575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027986575&partnerID=8YFLogxK

U2 - 10.1006/mvre.1994.1050

DO - 10.1006/mvre.1994.1050

M3 - Article

C2 - 7854206

AN - SCOPUS:0027986575

VL - 48

SP - 212

EP - 235

JO - Microvascular Research

JF - Microvascular Research

SN - 0026-2862

IS - 2

ER -